Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMB9N4J)

Drug Name

ABT-957 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Calpain-2 (CAPN2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID25399719-Compound-17	DMRXKJZ	N. A.	N. A.	Patented	[3]
Epoxysuccinate derivative 9	DM49FU0	N. A.	N. A.	Patented	[3]
Epoxysuccinate derivative 4	DMCF6M8	N. A.	N. A.	Patented	[3]
Carboxamide derivative 7	DM8TQS4	N. A.	N. A.	Patented	[3]
Epoxysuccinate derivative 7	DMTSPVF	N. A.	N. A.	Patented	[3]
Carboxamide derivative 10	DM5WMO9	N. A.	N. A.	Patented	[3]
Carboxamide derivative 11	DM1DN94	N. A.	N. A.	Patented	[3]
Carboxamide derivative 8	DM6HI34	N. A.	N. A.	Patented	[3]
Epoxysuccinate derivative 10	DMYF39U	N. A.	N. A.	Patented	[3]
Carboxamide derivative 6	DM6GZW4	N. A.	N. A.	Patented	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT02220738) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors. U.S. National Institutes of Health.
2	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3	An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.